Hydrastine
From Wikipedia, the free encyclopedia
 |
|
|
Hydrastine
|
|
| Systematic (IUPAC) name | |
| 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinoline-5-yl)-1(3H)-isobenzo furan | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H21NO6 |
| Mol. mass | 383.395 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Hydrastine is a natural alkaloid which was discovered in 1851 by Alfred P. Durand. By hydrolysis of hydrastine one receives Hydrastinine, which was patented by Bayer as a haemostatic drug during 1910s.
It is naturally present in Hydrastis canadensis (thus the name) and other plants of the ranunculaceae.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 |
This biochemistry article is a stub. You can help Wikipedia by expanding it. |
